Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. (2021)
Attributed to:
Next Generation Biomaterials Discovery
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics13020208
PubMed Identifier: 33546301
Publication URI: http://europepmc.org/abstract/MED/33546301
Type: Journal Article/Review
Volume: 13
Parent Publication: Pharmaceutics
Issue: 2
ISSN: 1999-4923